Lv4
460 积分 2025-01-28 加入
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis
4天前
已完结
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation
4天前
已完结
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
4天前
已完结
Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review, Meta‐Analysis, and Meta‐Regression
5天前
已完结
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis
1个月前
已完结
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?
1个月前
已完结
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation
1个月前
已完结
Progress in prevention and treatment of cytomegalovirus infection in patients with allogeneic hematopoietic stem cell transplantation
1个月前
已完结
皖公网安备34019202002308
